From Medscape Oncology

Coverage From The

American Society of Hematology (ASH) 2020 Annual Meeting

December 05 - 08, 2020; Virtual Meeting

December 05 - 08, 2020 Virtual Meeting

ASH 2020 'Practice Changing': Ruxolitinib as Second-Line in Chronic GVHD A significant advantage was observed for ruxolitinib, as compared with standard therapy, for the treatment of chronic graft-versus-host disease (GVHD).
Medscape Medical News, December 7, 2020
ASH 2020 No Benefit From Tranexamic Acid Prophylaxis in Blood Cancers Tranexamic acid prophylaxis did not reduce bleeding among patients with hematologic malignancies and severe thrombocytopenia and may do more harm than good.
Medscape Medical News, December 7, 2020
ASH 2020 In MDS, Transplant Ups Survival in Elderly and May Be Reimbursed Transplants offer a chance for a cure in myelodysplastic syndrome, and are often offered to younger patients; new results show they increase survival in older patients too.
Medscape Medical News, December 4, 2020

Conference News

ASH 2020 On the Horizon: Asciminib, a New Drug for Treating R/R CML
Medscape Medical News, December 14, 2020
ASH 2020 Mycophenolate Shows Promise in Immune Thrombocytopenia
Medscape Medical News, December 14, 2020
ASH 2020 Model May Predict Post-treatment Hodgkin Lymphoma Outcomes
Medscape News UK, December 11, 2020
ASH 2020 First Data for CAR T-cell Therapy in Follicular Lymphoma
Medscape Medical News, December 11, 2020
ASH 2020 Steroids Increase Infection Risk With CAR T-Cell Therapy in NHL
Medscape News UK, December 10, 2020
ASH 2020 Black Race Linked to Poorer Survival in AML
Medscape Medical News, December 9, 2020
ASH 2020 Durable Responses With Anti-BCMA CAR T-cell for Multiple Myeloma
Medscape Medical News, December 9, 2020
ASH 2020 Five-Minute SC Injection of Daratumumab in R/R Multiple Myeloma
Medscape Medical News, December 8, 2020

ASH 2020 Allogeneic Transplant: Durable Remissions in T-Cell Lymphomas
Medscape Medical News, December 8, 2020
ASH 2020 Early Responders Could Halt Advanced CLL Combo Therapy
Medscape News UK, December 8, 2020
ASH 2020 Fixed Duration Ibrutinib/Venetoclax Feasible for Some CLL/SLL
Medscape Medical News, December 8, 2020
ASH 2020 Duvelisib Response Rate 'Exciting' in Patients With r/r PTCL
Medscape Medical News, December 8, 2020
ASH 2020 COVID-19 Outcomes Poor for Patients With Hematologic Disease
Medscape Medical News, December 8, 2020
ASH 2020 'Practice Changing': Ruxolitinib as Second-Line in Chronic GVHD
Medscape Medical News, December 7, 2020
ASH 2020 No Benefit From Tranexamic Acid Prophylaxis in Blood Cancers
Medscape Medical News, December 7, 2020
ASH 2020 In MDS, Transplant Ups Survival in Elderly and May Be Reimbursed
Medscape Medical News, December 4, 2020

Medscape Oncology© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Popular News from ASH 2019

Some Patients with DLBCL Can Skip Radiation: 'It's a Win' A 'no radiation' approach may be possible for managing non-bulky (stage I/II) disease in patients with DLBCL. These patients may do well with just 4 cycles of R-CHOP after an interim PET-negative scan.
Medscape Medical News, Dec 08, 2019
Oral Azacitidine: First Maintenance Therapy for AML A new oral formulation of azacitidine (CC-486) significantly improved overall survival when used as maintenance therapy in patients with acute myeloid leukemia (AML).
Medscape Medical News, Dec 10, 2019
No Decreased Survival in Blacks With AML Compared With Whites Although blacks with acute myeloid leukemia were more likely to have evidence of abnormal kidney function, the excess of this comorbidity didn't affect overall survival, compared with whites.
Medscape Medical News, Dec 08, 2019

Perspectives

Key Presentations on Acute Myeloid Leukemia From ASH 2020
Eunice S. Wang, MD
Key Presentations on Myelodysplastic Syndrome From ASH 2020
Harry P. Erba, MD, PhD
Advances in Multiple Myeloma From ASH 2020
Joseph Mikhael, MD
Highlights in CML From ASH 2020
Jorge E. Cortes, MD
Highlights in Acute Lymphoblastic Leukemia From ASH 2020
Mark R. Litzow, MD
Highlights in Mantle Cell Lymphoma From ASH 2020
Amanda F. Cashen, MD
Highlights in Chronic Lymphocytic Leukemia From ASH 2020
William G. Wierda, MD, PhD

Previous Conferences